Janette Contreras‐De Lama

Statistics

Publications

Citations

114

H-Index

Active since

2021

Affiliations

Albert Einstein College of Medicine(Current)

AbbVie (United States)

Open Health Systems Laboratory

Janette Contreras‐De Lama is an author at Albert Einstein College of Medicine specializing in acute migraine treatment, calcitonin gene-related peptide monoclonal antibodies, and preventive migraine therapy.

Publications per year

2021–2023

Publications

Pharmacokinetics and safety of ubrogepant when coadministered with calcitonin gene‒related peptide‐targeted monoclonal antibody migraine preventives in participants with migraine: A randomized phase 1b drug–drug interaction study

Abhijeet Jakate, Andrew Blumenfeld, Ramesh Boinpally et al. · Headache The Journal of Head and Face Pain · 2021 · 71 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Real-world effectiveness, satisfaction, and optimization of ubrogepant for the acute treatment of migraine in combination with onabotulinumtoxinA: results from the COURAGE Study

Aubrey Manack Adams, Susan Hutchinson, Ella Engstrom et al. · The Journal of Headache and Pain · 2023 · 18 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Pre- and post-headache phases of migraine: multi-country results from the CaMEO – International Study

Richard B. Lipton, Michel Lantéri‐Minet, Élizabeth Leroux et al. · The Journal of Headache and Pain · 2023 · 13 citations · Full text

Medicine, Neurology, Behavioral Health +13

Real-World Use of Ubrogepant as Acute Treatment for Migraine with an Anti-Calcitonin Gene-Related Peptide Monoclonal Antibody: Results from COURAGE

Richard B. Lipton, Janette Contreras‐De Lama, Daniel Serrano et al. · Neurology and Therapy · 2023 · 12 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

1–4 of 4